COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 2096: Articles 20951-20960  | Next

Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Dufloo, J., Grzelak, L., Staropoli, I., Madec, Y., Tondeur, L., Anna, F., Pelleau, S., Wiedemann, A., Planchais, C., Buchrieser, J., Robinot, R., Ungeheuer, M.-N., Mouquet, H., Charneau, P., White, M., Levy, Y., Hoen, B., Fontanet, A., Schwartz, O., Bruel, T.
10.1101/2020.11.12.20230508 — Posted: 2020-11-15
Modelling the positive testing rate of COVID-19 in South Africa Using A Semi-Parametric Smoother for Binomial Data
Owokotomo, O. E., Manda, S., Kasim, A., Claesen, J., Shkedy, Z., Reddy, T.
10.1101/2020.11.11.20230250 — Posted: 2020-11-15
Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data
Stirrup, O. T., Hughes, J., Parker, M., Partridge, D., Shepherd, J. G., Blackstone, J., Coll, F., Keeley, A. J., Lindsey, B. B., Marek, A., Peters, C., Singer, J. B., The COVID-19 Genomics UK (COG-UK) consortium, , Tamuri, A., de Silva, T. I., Thomson, E. C., Breuer, J. C.
10.1101/2020.11.12.20230326 — Posted: 2020-11-15
The implementation of remote home monitoring models during the COVID-19 pandemic in England
Vindrola-Padros, C., Sidhu, M., Georghiou, T., Sherlaw-Johnson, C., Singh, K., Tomini, S., Ellins, J., Morris, S., Fulop, N. J.
10.1101/2020.11.12.20230318 — Posted: 2020-11-15
Low uptake of COVID-19 prevention behaviours and high socioeconomic impact of lockdown measures in South Asia: evidence from a large-scale multi-country surveillance programme
Kusuma, D., Pradeepa, R., Khawaja, K. I., Hasan, M., Siddiqui, S., Mahmood, S., Ali Shah, S. M., De Silva, C. K., de Silva, L., Gamage, M., Loomba, M., Rajakaruna, V. P., Hanif, A. A., Kamalesh, R. B., Kumarendran, B., Loh, M., Misra, A., Tassawar, A., Tyagi, A., Waghdhare, S., Burney, S., Ahmad, S., Mohan, V., Sarker, M., Goon, I. Y., Kasturiratne, A., Kooner, J. S., Katulanda, P., Jha, S., Anjana, R. M., Mridha, M. K., Sassi, F., Chambers, J.
10.1101/2020.11.12.20229898 — Posted: 2020-11-14 Discussion: Offsite
Analysis of the Dynamics and Distribution of SARS-CoV-2 Mutations and its Possible Structural and Functional Implications
Justo Arevalo, S., Zapata Sifuentes, D., Huallpa Robles, C., Landa Bianchi, G., Castillo Chavez, A., Garavito-Salini Casas, R., Pineda Chavarria, R., Uceda-Campos, G.
10.1101/2020.11.13.381228 — Posted: 2020-11-14
A comparison of DNA/RNA extraction protocols for high-throughput sequencing of microbial communities
Shaffer, J. P., Marotz, C., Belda-Ferre, P., Martino, C., Wandro, S., Estaki, M., Salido, R. A., Carpenter, C. S., Zaramela, L. S., Minich, J. J., Bryant, M. B., Sanders, K., Fraraccio, S., Ackermann, G., Humphrey, G., Swafford, A. D., Miller-Montgomery, S., Knight, R.
10.1101/2020.11.13.370387 — Posted: 2020-11-14
A Whole Virion Vaccine for COVID-19 Produced Via a Novel Inactivation Method: Results from Animal Challenge Model Studies
Ragan, I. K., Hartson, L. M., Dutt, T. S., Obregon-Henao, A., Maison, R. M., Gordy, P., Fox, A., Karger, B. R., Cross, S. T., Kapuscinski, M. L., Cooper, S. K., Podell, B. K., Stenglein, M. D., Bowen, R. A., Henao-Tamayo, M., Goodrich, R.
10.1101/2020.11.13.381335 — Posted: 2020-11-13
Plasma irradiation efficiently inactivates the coronaviruses mouse hepatitis virus and SARS-CoV-2
Morikawa, S., Watanabe, S., Fujii, H., Tanaka, T., Arai, J., Kyuwa, S.
10.1101/2020.11.13.381319 — Posted: 2020-11-13
ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2
Tribolet, L., Alexander, M., Brice, A., Jansen Van Vuren, P., Rootes, C., Mara, K., McDonald, M., Bruce, K., Gough, T., Shi, S., Cowled, C., Bean, A., Stewart, C. R.
10.1101/2020.11.13.381343 — Posted: 2020-11-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).